
Meet Diana Stoycheva at IO360 in New York
Meet Diana Stoycheva at IO360 in New York
Scailyte is excited to share that our principal scientist Diana Stoycheva, an expert in the field of #ImmunoOncology, will be representing our company at The Conference Forum‘s IO360 conference in New York from February 7-10, 2023! Proud to have her share our work at this distinguished event and contribute to the advancement of the industry. Connect with her to discuss the latest developments and challenges in immunotherapy.
About Scailyte
Scailyte is an ETH Zürich spin-off with a best-in-class artificial intelligence platform for the discovery of complex disease patterns from single-cell data. Our solution provides unprecedented insight into the disease and patients’ biology and enables the discovery of new clinically-relevant biomarker signatures by uncovering human’s hidden “single-cell” secrets.
Scailyte’s proprietary best-in-class data analysis platform ScaiVision™ associates multimodal single-cell datasets (RNA-/TCR-/BCR-seq, proteomics, etc.) with clinical endpoints, such as disease diagnosis, progression, severity, treatment response, and toxicity response to identify ultra-sensitive biomarker signatures and cell functionality states. The performance and clinically-relevant applications of Scailyte’s platform ScaiVision have been demonstrated in well established CAR-T cell therapies and various clinical projects in Oncology and Immunology.
Recent News
NextGen Omics Boston Conference
Scailyte will be attending the upcoming NextGen Omics Boston conference, taking place on March 30-31
Recent News
Vijay Tiwari is appointed as Chair of the Scientific Advisory Board
Vijay Tiwari is appointed as the Chair of Scailyte's Scientific Advisory Board
Recent News
Endometriosis interview series
We mark Endometriosis Awareness Month, and Scailyte is proud to support this cause with the “Endom
Recent News
Scailyte Announces a Collaboration with Turnstone Biologics
Scailyte Announces Collaboration with Turnstone Biologics to Identify Biomarker Signatures in Solid
Recent News
BIO-Europe Spring 2023
We will be attending the 17th annual BIO-Europe Spring taking place from 20-22 March 2023 in Basel.
Recent News
Deciphering Disease Mechanisms Through Functional Genomics
Tiwari lab studies gene-epigenetic interplay in cell identity & its disruption in cancer/neurologica
Recent News
International Women's Day 2023
Scailyte celebrates International Women’s day and praises all women Scailyters: smart, trailblazin
Recent News
Diana Stoycheva and Sarah Carl at Biomarkers 2023
We are excited to announce our attendance at Oxford Global Conferences' Biomarkers 2023! Our team, i
Recent News
NextGen Omics Boston Conference
Scailyte will be attending the upcoming NextGen Omics Boston conference, taking place on March 30-31
Vijay Tiwari is appointed as Chair of the Scientific Advisory Board
Vijay Tiwari is appointed as the Chair of Scailyte's Scientific Advisory Board
Recent News
Endometriosis interview series
We mark Endometriosis Awareness Month, and Scailyte is proud to support this cause with the “Endom
Scailyte Announces a Collaboration with Turnstone Biologics
Scailyte Announces Collaboration with Turnstone Biologics to Identify Biomarker Signatures in Solid
Recent News
BIO-Europe Spring 2023
We will be attending the 17th annual BIO-Europe Spring taking place from 20-22 March 2023 in Basel.
Deciphering Disease Mechanisms Through Functional Genomics
Tiwari lab studies gene-epigenetic interplay in cell identity & its disruption in cancer/neurologica
Recent News
International Women's Day 2023
Scailyte celebrates International Women’s day and praises all women Scailyters: smart, trailblazin
Diana Stoycheva and Sarah Carl at Biomarkers 2023
We are excited to announce our attendance at Oxford Global Conferences' Biomarkers 2023! Our team, i